Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,595
Total Claims
$2.6M
Drug Cost
913
Beneficiaries
$2,855
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+167%
Cost per patient vs peers
$2,855 vs $1,068 avg
+14%
Brand preference vs peers
10.3% vs 9.0% avg
Brand vs Generic
Brand: 2,621 claims · $2.1M
Generic: 22,819 claims · $514K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 219 | $266K |
| Linagliptin | 225 | $229K |
| Dapagliflozin Propanediol | 190 | $183K |
| Sitagliptin Phosphate | 116 | $169K |
| Dulaglutide | 117 | $148K |
| Denosumab | 75 | $130K |
| Apixaban | 85 | $98K |
| Tenofovir Alafenamide | 64 | $93K |
| Rivaroxaban | 87 | $88K |
| Mirabegron | 128 | $87K |
| Fluticasone/Umeclidin/Vilanter | 97 | $74K |
| Sacubitril/Valsartan | 79 | $73K |
| Linaclotide | 99 | $59K |
| Cyclosporine | 81 | $57K |
| Semaglutide | 24 | $50K |
Prescribing Profile
Patient Profile
76
Avg Age
59%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data